Search Results for 'Arvs'

Arvs published presentations and documents on DocSlides.

by alexa-scheidler

do not get rid of HIV from the body – they stop...

This job tool was created by ICAP at Columbia University with funding from the U.S. President’s E

This job tool was created by ICAP at Columbia University with funding from the U.S. President’s E

by marina-yarberry

the Centers. for Disease Control and Prevention...

Module 2: Supporting Behavior Change

Module 2: Supporting Behavior Change

by pamella-moone

Learning Objectives. Understand key counseling te...

Module 2: Supporting Behavior Change

Module 2: Supporting Behavior Change

by mitsue-stanley

Module 2: Supporting Behavior Change Learning Ob...

by lucinda

1 J i v i n g w i t h S c i e n c e C D 1 E n g l ...

How Advocacy can Influence Pricing &

How Advocacy can Influence Pricing &

by mia

P. olicy. Jessica Burry. HIV/HCV Pharmacist. July ...

Viral Load Monitoring and Enhanced

Viral Load Monitoring and Enhanced

by esther

Adherence. Counseling. Flipchart. Adults, non-preg...

ARVs & DDIs in pregnancy

ARVs & DDIs in pregnancy

by obrien

Scientific Workshop. Improving patient care throug...

Budget issues driving/affecting treatment choice:

Budget issues driving/affecting treatment choice:

by pamella-moone

Community involvement in the . London ARV tender ...

Pharmaceutical Patents,

Pharmaceutical Patents,

by stefany-barnette

TRIPS Flexibilities and . Access to Medicines in ...

by luanne-stotts

GENERIC ARVs. Tim Horn. Treatment Action Group. t...

Phase 2 of new ARVs

Phase 2 of new ARVs

by mitsue-stanley

Fostemsavir. , . prodrug. of . temsavir. . (. a...

by stefany-barnette

S Abdool Karim. Director. : CAPRISA. Pro Vice-Cha...

Adolescent HIV Care and Treatment

Adolescent HIV Care and Treatment

by tatiana-dople

Module 11:. Family Planning and PMTCT Services fo...

by natalia-silvester

do not get rid of HIV from the body – they stop...

Case Presentation Brandon White, BSN, RN, PHN

Case Presentation Brandon White, BSN, RN, PHN

by liane-varnes

Marion County Public Health Department. Northwest...

Issues Affecting ART Success: Adherence, ARV Toxicity, Drug Interactions

Issues Affecting ART Success: Adherence, ARV Toxicity, Drug Interactions

by pamella-moone

Guidelines for the Use of Antiretroviral Agents i...

Mechanisms to address IP related Barriers

Mechanisms to address IP related Barriers

by kittie-lecroy

. in . Middle-Income Countries. Othoman. Mellou...

The Future of HIV Treatment

The Future of HIV Treatment

by myesha-ticknor

Greg Perry. Melbourne – International AIDS Conf...

Affordability of HIV/AIDS treatment in developing countries: modeling ARV drug price determinants f

Affordability of HIV/AIDS treatment in developing countries: modeling ARV drug price determinants f

by marina-yarberry

functioning. Luis . Sagaon. . Teyssier. ; Yves A...

Projecting the Impact of

Projecting the Impact of

by marina-yarberry

Generic. HIV . Drugs. on 90-90-90. Esteban Burr...

Diagnosis and Initial Management of HIV/AIDS:

Diagnosis and Initial Management of HIV/AIDS:

by cheryl-pisano

What the Primary Care Provider Should Know. Carol...

What Happens to HIV Programs When Donors Leave?

What Happens to HIV Programs When Donors Leave?

by luanne-stotts

. The GFATM procurement cliff. Sharonann Lynch. ...

Opportunities for the use of new ARVs for infants, children and adolescents and updated guidance on

Opportunities for the use of new ARVs for infants, children and adolescents and updated guidance on

by myesha-ticknor

Martina Penazzato MD, PhD. Paediatric lead, HIV D...

Acceleration part 1: Prioritization and clinical research of priority formulations

Acceleration part 1: Prioritization and clinical research of priority formulations

by lindy-dunigan

Elaine Abrams and Carlo . Giaquinto. Disclosure. ...

Guideline Summary Updated

Guideline Summary Updated

by stefany-barnette

U.S. . Public Health Service Guidelines for the M...

Phase 2 of new ARVs Fostemsavir

Phase 2 of new ARVs Fostemsavir

by conchita-marotz

, . prodrug. of . temsavir. . (attachment inhib...

Basic principles of DDIs with ARVs: an introduction David Back

Basic principles of DDIs with ARVs: an introduction David Back

by marina-yarberry

Basic principles of DDIs with ARVs: an introducti...

Clinical aspects of ADRs in HIV and ARV toxicity monitoring approaches

Clinical aspects of ADRs in HIV and ARV toxicity monitoring approaches

by myesha-ticknor

Clinical aspects of ADRs in HIV and ARV toxicity ...

Issues Affecting ART Success: Adherence, ARV Toxicity, Drug Interactions

Issues Affecting ART Success: Adherence, ARV Toxicity, Drug Interactions

by genesantander

Guidelines for the Use of Antiretroviral Agents in...

Phase 2 of new ARVs Fostemsavir

Phase 2 of new ARVs Fostemsavir

by sportyinds

, . prodrug. of . temsavir. . (. attachment inhi...

Monday, 23 July, 10:15-12:15

Monday, 23 July, 10:15-12:15

by della

Hall 11B, RAI Amsterdam. Uptake and Procurement of...

India’s Pharma Exports

India’s Pharma Exports

by emmy

Contribution to Global Health. . Pha...

This project has been supported by the President’s Emergency Plan for AIDS Relief (PEPFAR) throug

This project has been supported by the President’s Emergency Plan for AIDS Relief (PEPFAR) throug

by paige

Counseling Instructions. Introduction to LPV/r . g...

Module 1: Principles of Viral Load Monitoring

Module 1: Principles of Viral Load Monitoring

by braylon

Learning Objectives. Understand the dynamics of vi...